We provide disease-relevant cell-based assay readouts to meet your research needs in drug discovery and development. Our range of testing options include target-based and phenotypic readouts, immunofluorescence (ICC), FRET, cell painting, customized multiplexing of stains, and more. Our cell-based assay readouts offer several advantages over traditional biochemical assays, including: more physiologically relevant results, increased predictive power, interrogation of signaling pathways.